Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -46.54% is in line with its 2-year average of -45.94%, around the middle of its 2-year range (-103.64%–-18.69%).
As of the fiscal period ended Tuesday, June 30, 2026. 31.15% below its 12-month average of -35.49%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -46.54%.
RETURN ON INVESTED CAPITAL (ROIC)
-46.54%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-35.49%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-31.15%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-26.34%
median of 380 covered companies
CURRENT VS SECTOR MEDIAN
-76.74%
vs the sector median at left
CeriBell, Inc.
Market Cap
$943.26M
Return on Invested Capital (ROIC)
-46.54%
TTM Avg
-35.49%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$922.50M
Return on Invested Capital (ROIC)
54.39%
TTM Avg
-47.91%
3Y Avg
-50.01%
5Y Avg
-47.22%
Market Cap
$915.95M
Return on Invested Capital (ROIC)
11.37%
TTM Avg
4.29%
3Y Avg
-4.73%
5Y Avg
-2.12%
Market Cap
$903.13M
Return on Invested Capital (ROIC)
-25.25%
TTM Avg
-75.69%
3Y Avg
-67.13%
5Y Avg
-61.15%
Market Cap
$985.79M
Return on Invested Capital (ROIC)
-68.64%
TTM Avg
-46.08%
3Y Avg
-28.67%
5Y Avg
-26.80%
Market Cap
$989.05M
Return on Invested Capital (ROIC)
-16.54%
TTM Avg
-24.45%
3Y Avg
-23.43%
5Y Avg
-23.43%
Market Cap
$867.60M
Return on Invested Capital (ROIC)
-28.69%
TTM Avg
-21.44%
3Y Avg
-33.52%
5Y Avg
-49.04%
Market Cap
$866.15M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$852.55M
Return on Invested Capital (ROIC)
-31.17%
TTM Avg
-29.64%
3Y Avg
-85.48%
5Y Avg
-85.48%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CeriBell, Inc. (CBLL) | $943.26M | -46.54% | -35.49% | N/A | N/A |
| Arbutus Biopharma Corp (ABUS)vs › | $922.50M | 54.39% | -47.91% | -50.01% | -47.22% |
| Bioventus Inc. (BVS)vs › | $915.95M | 11.37% | 4.29% | -4.73% | -2.12% |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $903.13M | -25.25% | -75.69% | -67.13% | -61.15% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $985.79M | -68.64% | -46.08% | -28.67% | -26.80% |
| Aktis Oncology, Inc. (AKTS)vs › | $989.05M | -16.54% | -24.45% | -23.43% | -23.43% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $867.60M | -28.69% | -21.44% | -33.52% | -49.04% |
| Apnimed, Inc. (APMD)vs › | $866.15M | N/A | N/A | N/A | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $852.55M | -31.17% | -29.64% | -85.48% | -85.48% |
| Alumis Inc. (ALMS)vs › | $844.28M | -94.76% | -114.06% | -144.57% | -144.57% |
ROIC
-46.5%
ROE
-51.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -46.54% |
| 2026-03-31 | -40.11% |
| 2025-12-31 | -33.07% |
| 2025-09-30 | -30.75% |
| 2025-06-30 | -26.98% |
| 2025-03-31 | -22.55% |
| 2024-12-31 | -18.69% |
| 2024-09-30 | -103.64% |
| 2024-06-30 | -75.92% |
| 2023-12-31 | -61.11% |
